AMETEK Announces Record Second Quarter 2026 Results and Raises Full Year Guidance

AMETEK posts record Q2 results with double-digit growth across all key metrics.

Risk flags

• ●The announcement does not provide prior year (Q2 2025) absolute figures for key metrics such as sales, operating income, or cash flow, making it impossible to independently verify the percentage increases claimed. This limits the transparency and comparability of the reported growth rates.
• ●Qualitative descriptors such as 'exceptional' for order growth are not benchmarked against industry peers or historical averages, which could overstate the significance of the result in the absence of context.
• ●Forward-looking guidance for Q3 and full-year 2026 is not accompanied by detailed assumptions or backlog data, introducing uncertainty around the achievability of projected 10–12% EPS growth.

Bottom line

AMETEK delivered record Q2 2026 results, with double-digit growth in sales, earnings, cash flow, and orders, supported by detailed segment and margin disclosures. The company's narrative is credible, as nearly all key metrics are realised and transparently reported for the current period. The main limitation is the absence of prior year absolute numbers, which restricts independent verification of the claimed growth rates. Forward guidance for the rest of 2026 is positive but lacks detailed supporting assumptions. Investors should view these results as a strong signal of operational momentum, but would benefit from more granular historical data to fully assess the sustainability of growth. The most important takeaway is that AMETEK is currently executing at a high level, with no evidence of hype or overstatement in its reporting.

Announcement summary

(NYSE: AME) AMETEK, Inc. announced its financial results for the second quarter ended June 30, 2026, reporting record sales of $2.04 billion, a 15% increase over the second quarter of 2025. Second quarter GAAP earnings were a record $1.77 per diluted share, while adjusted earnings reached a record $2.09 per diluted share, up 17% from the prior year. GAAP operating income was $528.2 million, and adjusted operating income increased 18% to $544.4 million, with operating margins at 26.6%, up 60 basis points from the prior year. Operating cash flow in the quarter rose 35% to $483.7 million, and free cash flow to net income conversion was 111%. Orders grew 28% in the quarter, and EIG sales were $1.32 billion, up 14%, while EMG sales were a record $723.2 million, up 17%. The company projects full-year 2026 overall sales to be up approximately 10% versus 2025 and adjusted earnings per diluted share in the range of $8.20 to $8.30, up 10% to 12% over 2025.

Disagree with this article?